• Skip to primary navigation
  • Skip to main content
  • Skip to footer
MotherToBaby

MotherToBaby

Medications and More during pregnancy and breastfeeding

Search

Hide Search
Shopping Cart
Show SearchSearch
866.626.6847
  • About
    • Our Work
    • Our Team
    • Our Partners
    • Our Impact
  • Exposures
    • Pregnancy and Breastfeeding Exposures
    • Fact Sheets
    • Baby Blogs
    • Podcasts
    • Interactive Tool
    • Other Educational Tools
    • LactRx App
  • Studies
    • Ongoing Studies
    • What’s Involved?
    • Join Now
    • Refer a Patient
    • Health Providers
    • Pharma Industry
    • Publications
  • Health Professionals
    • Patient Education and Provider Resources
    • Refer a Patient
    • Request Materials
    • Meetings
    • FAQs
    • OTIS Membership
  • Media
    • Media Requests
    • Press Releases
    • eNews Sign Up
  • In Your Area
  • OTIS
    • About OTIS
    • OTIS Membership
    • Annual Meeting
    • Member Log-In
  • Donate
  • Contact
  • Show SearchSearch

Meningococcal Vaccines

March 1, 2025

Selected References:  

  • AbuRaya B, Sadarangani M. 2018. Meningococcal vaccination in pregnancy. Hum Vaccin Immunother 14(4):1188-1196.  
  • Becerra-Culqui, T. A., et al. 2020. Safety of MenACWY-CRM vaccine exposure during pregnancy. Vaccine, 38(12), 2683–2690. 
  • Becerra-Culqui TA. et al. 2020. Safety of quadrivalent meningococcal conjugate vaccine in infants and toddlers 2 to 23-months old. Vaccine 38(2), 228-234.  
  • Becerra-Culqui TA, et al. 2021. Real-world evidence of quadrivalent meningococcal conjugate vaccine safety in the United States: a systematic review. Hum Vaccin Immunother, 17(5):1432-1441. 
  • Clark, D. R., et al. 2020. Influenza or Meningococcal Immunization During Pregnancy and Mortality in Women and Infants: A Pooled Analysis of Randomized Controlled Trials. The Pediatric Infectious Disease Journal, 39(7), 641–644. 
  • Crum-Cianflone, N., & Sullivan, E. 2016. Meningococcal Vaccinations. Infectious Diseases and Therapy, 5(2), 89–112. 
  • Findlow H, et al. 2019. Kinetics of maternally-derived serogroup A, C, Y and W-specific meningococcal immunoglobulin G in Malian women and infants. Vaccine, 37(18), 2477–2481. 
  • GlaxoSmithKline Biologicals SA. 2020. Menveo product labeling. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2dc730d5-55fd-4e98-8c8a-daa7d8f872b0. Accessed 16 May 2025.    
  • Letson GW, et al. 1998. Meningococcal vaccine in pregnancy: an assessment of infant risk. Pediatr Infect Dis J 17:261-263.  
  • Mbaeyi SA, et al. 2020. Meningococcal Vaccination: Recommendations of the Advisory Committee on Immunization Practices, United States, 2020. MMWR Recommendations and Reports, 69(9), 1–41. 
  • Myers TR, et al. 2020. Adverse events following quadrivalent meningococcal diphtheria toxoid conjugate vaccine (Menactra®) reported to the Vaccine Adverse Event Reporting System (VAERS), 2005–2016. Vaccine, 38(40), 6291–6298. 
  • Nasser R, et al. 2020. Are all vaccines safe for the pregnant traveler? A systematic review and meta-analysis. Journal of Travel Medicine, 27(2). 
  • National Center for Immunization and Respiratory Diseases. 2011. General recommendations on immunization — recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 28;60(2):1-64. Erratum in: MMWR Recomm Rep; 60:993. 
  • Psarris A, et al. 2019. Immunizations during pregnancy: How, when and why. European Journal of Obstetrics & Gynecology and Reproductive Biology, 240, 29–35. 
  • The Centers for Disease Control and Prevention (CDC). https://www.cdc.gov/vaccines/vpd/mening/index.html. Acessed 16 May 2025. 
  • World Health Organization (WHO). 2015. Meningococcal A conjugate vaccine: updated guidance, February 2015. Weekly epidemiological record. No. 8, 90: 57-62. 
  • Zheteyeva Y, et al. 2013. Safety of meningococcal polysaccharide-protein conjugate vaccine in pregnancy: a review of the Vaccine Adverse Event Reporting System. Am J Obstet Gynecol.; 208(6):478.e1-6.  

 

Footer

               

Hot Links

  • Home
  • Exposures
  • Fact Sheets
  • Baby Blogs
  • Podcasts
  • Pregnancy Studies
  • Join a Study Now
  • Healthcare Professionals
  • Refer a Patient
  • Request Materials
  • News
  • Donate
  • Ask An Expert

Current Studies

  • Ankylosing Spondylitis
  • Constipation
  • Coronavirus (COVID-19)
  • Eczema (Moderate-to-Severe)/Atopic Dermatitis
  • Hidradenitis Suppurativa
  • Lupus
  • Multiple Sclerosis
  • Non-Radiographic Axial Spondyloarthritis
  • Psoriasis
  • Psoriatic Arthritis

Contact

Exposure Information Service
866.626.6847

Pregnancy Studies
877.311.8972

Media Inquiries
619.368.3259
nchavez@mothertobaby.org

MotherToBaby, a service of the Organization of Teratology Information Specialists

Copyright © 2025 The Organization of Teratology Information Specialists

  • Accessibility
  • Privacy
  • Terms
  • Site Map
^

This website is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of an award totaling $6,000,000 with zero percentage financed with non-governmental sources. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, HRSA, HHS, or the U.S. Government.